High S100A9 levels in peripheral blood monocytes and a lower ratio of CD4+ T cells/monocyte was previously found to correlate positively with poor response to anti-PD-1 immunotherapy but inversely with overall survival in melanoma patients (30). The gene discussed is S100A9; the disease is melanoma.